ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 17 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $34,266,000 | +33.6% | 19,000,000 | 0.0% | 1.69% | +8.2% |
| Q2 2017 | $25,656,000 | +101.0% | 19,000,000 | +111.1% | 1.56% | +88.6% |
| Q1 2017 | $12,763,000 | +1.3% | 9,000,000 | 0.0% | 0.83% | -23.8% |
| Q4 2016 | $12,593,000 | +164.5% | 9,000,000 | +125.0% | 1.09% | +186.5% |
| Q3 2016 | $4,761,000 | +40.8% | 4,000,000 | 0.0% | 0.38% | +17.3% |
| Q2 2016 | $3,382,000 | +5.0% | 4,000,000 | 0.0% | 0.32% | -2.1% |
| Q1 2016 | $3,220,000 | -13.0% | 4,000,000 | 0.0% | 0.33% | +19.1% |
| Q4 2015 | $3,702,000 | -6.1% | 4,000,000 | 0.0% | 0.28% | -7.4% |
| Q3 2015 | $3,942,000 | -21.9% | 4,000,000 | 0.0% | 0.30% | -27.8% |
| Q2 2015 | $5,050,000 | +0.6% | 4,000,000 | 0.0% | 0.41% | -8.2% |
| Q1 2015 | $5,022,000 | +168.7% | 4,000,000 | +100.0% | 0.45% | +122.2% |
| Q4 2014 | $1,869,000 | -45.7% | 2,000,000 | -33.3% | 0.20% | -60.9% |
| Q3 2013 | $3,444,000 | +20.5% | 3,000,000 | 0.0% | 0.52% | +3.0% |
| Q2 2013 | $2,859,000 | – | 3,000,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 16,000,000 | $14,400,000 | 2.99% |
| Mohican Financial Management, LLC | 3,500,000 | $3,097,000 | 1.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 34,000,000 | $29,918,000 | 1.09% |
| QVT Financial LP | 9,000,000 | $8,025,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,250,000 | $11,583,000 | 0.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,919,000 | $14,893,000 | 0.23% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 500,000 | $452,000 | 0.18% |
| CSS LLC/IL | 1,000,000 | $877,000 | 0.04% |
| Jefferies Group LLC | 1,500,000 | $1,328,000 | 0.01% |
| CREDIT AGRICOLE S A | 2,151,000 | $1,904,000 | 0.01% |